Americans are microdosing obesity drugs, driven by ‘thin is in’ marketing blitz
[Moneyweb - South Africa] - 30/11/2025
Doctors warn that microdosing copycat Ozempic and other GLP-1s is not approved for people with low BMIs and carries risks of serious side effects like pancreatic damage.
... Article published by "Moneyweb" (South Africa), read more
For any information or claim on this article, see directly with the newspaper.
In South African newspapers
Kaizer Chiefs kick off their CAF Confederation Cup group stage in Egypt. Here's the expected starting line-up to (…)
[The South African] - 22/11/2025
JSE slides as global tech weakness ripples through markets
SA equities were swept up in a global slump on Friday, with double-digit drops in Bitcoin and Ethereum.
[Moneyweb] - 21/11/2025
[Cape Times (IOL)] - 27/11/2025
As SA welcomes the world to the G20 Leaders’ Summit in Gauteng this weekend, here's what delegates can look forward (…)
[The South African] - 20/11/2025
